JANET WANG
Hematology & Oncology Physician · SANTA CRUZ, CA
Individual Active NPI 1760629158
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,038 | 304,624 | $17,953,345 | $6,733,578 | $5,350,728 |
| 2023 | 915 | 231,428 | $14,034,837 | $5,416,756 | $4,304,181 |
| 2022 | 852 | 181,296 | $9,953,937 | $4,007,312 | $3,183,306 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3262 | Injection, tocilizumab, 1 mg | 29,440 | $6 | $5 |
| J9271 | Injection, pembrolizumab, 1 mg | 24,000 | $56 | $45 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 21,420 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 15,020 | $31 | $25 |
| J1453 | Injection, fosaprepitant, 1 mg | 11,850 | $0 | $0 |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 11,400 | $0 | $0 |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 10,650 | $11 | $9 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 8,700 | $22 | $17 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 8,280 | $49 | $39 |
| J0897 | Injection, denosumab, 1 mg | 6,840 | $26 | $20 |
| J9030 | Bcg live intravesical instillation, 1 mg | 5,150 | $3 | $2 |
| J9267 | Injection, paclitaxel, 1 mg | 4,974 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | A120525 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in California
- NPI 1205860954
- NPI 1972821213
- NPI 1063537934
- NPI 1609886738
- NPI 1801942008
- NPI 1437269313
- NPI 1700850104
- NPI 1053632356
See all Hematology & Oncology Physician providers in California →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.